RESUMO
One hundred thirty-three infants and children with documented acute otitis media (OM) were randomized to receive the oral suspension of either amoxicillin-clavulanate potassium or cefaclor. Beta-lactamase-producing bacteria were found in 10.9 and 14.5% of subjects treated with amoxicillin-clavulanate potassium and cefaclor, respectively. Subjects were reexamined at 5, 10, 30, 60 and 90 days after the initiation of therapy and whenever signs/symptoms of acute otitis media recurred. All but two children had resolution of otalgia/otorrhea during the initial treatment period. The drug groups were not significantly different in the percentage of evaluable subjects with otitis media with effusion at each scheduled follow-up visit. Recurrence of acute OM/otorrhea [corrected] developed in a similar percentage of subjects in both treatment categories. Both subjects with and those without middle ear effusion at 10 days had approximately a 50% recurrence rate of subsequent middle ear disease. Adverse side effects/complaints, which occurred in significantly more children treated with amoxicillin-clavulanate potassium, were generally mild and primarily gastrointestinal.
Assuntos
Amoxicilina/uso terapêutico , Cefaclor/uso terapêutico , Cefalexina/análogos & derivados , Ácidos Clavulânicos/uso terapêutico , Otite Média/tratamento farmacológico , Doença Aguda , Combinação Amoxicilina e Clavulanato de Potássio , Criança , Pré-Escolar , Ensaios Clínicos como Assunto , Método Duplo-Cego , Combinação de Medicamentos/uso terapêutico , Dor de Orelha , Feminino , Febre , Humanos , Lactente , Masculino , Otite Média com Derrame/tratamento farmacológico , Distribuição Aleatória , RecidivaRESUMO
A double-blind randomized clinical trial was conducted at two sites comparing amoxicillin-clavulanate potassium (Augmentin) and amoxicillin trihydrate for the treatment of otitis media with effusion ("secretory otitis media"). One hundred eight subjects were randomly assigned to receive a ten-day course of either drug regimen. Clinical response was assessed at ten days and four weeks after entry. For those without middle ear effusion at four weeks, recurrence rates were measured at 8, 12, and 16 weeks after entry. At ten days following entry, 29 (51.8%) of 56 subjects in the amoxicillin-clavulanate-treated group were effusion free compared with 16 (32.0%) of 50 subjects in the amoxicillin-treated group (P = .06). At four weeks following entry, 26 (50.0%) of 50 subjects in the amoxicillin-clavulanate-treated group were effusion free compared with 23 (51.1%) of 45 subjects in the group given amoxicillin. By the 16-week visit, eight (36.4%) of 22 subjects in the amoxicillin-clavulanate-treated group who were effusion free at four weeks had recurrence of effusion, compared with 12 (63.2%) of 19 subjects in the amoxicillin-treated group. This study suggests that there was a favorable clinical response immediately following treatment in the amoxicillin-clavulanate--treated subjects as compared with those treated with amoxicillin, but this benefit was not sustained at the four-week end point.
Assuntos
Amoxicilina/uso terapêutico , Ácidos Clavulânicos/uso terapêutico , Otite Média com Derrame/tratamento farmacológico , Adolescente , Amoxicilina/efeitos adversos , Combinação Amoxicilina e Clavulanato de Potássio , Criança , Pré-Escolar , Ácidos Clavulânicos/efeitos adversos , Ensaios Clínicos como Assunto , Método Duplo-Cego , Combinação de Medicamentos/efeitos adversos , Combinação de Medicamentos/uso terapêutico , Feminino , Seguimentos , Humanos , Lactente , Masculino , Cooperação do Paciente , Distribuição Aleatória , RecidivaRESUMO
This review of patient and parent education, office laboratory procedures, and urinary tract infections is written by three pediatricians in a group practice in Pittsburgh, Pennsylvania. The patient and parent education section covers the goals of child rearing and history taking (with emphasis on the "vulnerable child"), and reviews discipline, sleep problems, fever, smoking, and injury prevention. The office laboratory procedures section reviews the recent Clinical Laboratory Improvement Act of 1988. The urinary tract infections section reviews recent advances in diagnosis, treatments, prevention (the issue of circumcision), and radiologic studies.
Assuntos
Técnicas de Laboratório Clínico/normas , Pais/educação , Educação de Pacientes como Assunto , Infecções Urinárias , Criança , Humanos , Legislação como Assunto , Estados UnidosRESUMO
A previously derived discriminant function for detecting classical PKU gene carriers without a priori pedigree probability was reevaluated using a large sample size. The test involves fluorometric measurement of fasting phenylalanine and tyrosine plasma levels. Among 75 controls and 45 known carriers, 95% could be classified as to their carrier status with greater than 98% accuracy. The accuracy of our method in classifying our population compared favorably to that of two other discriminant analysis methods requiring a priori probability.